Ine Lentacker

Ghent University — Belgium

Engineering · Physical Sciences

41h-index6.6kcitations139works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ultrasound and Hyperthermia Applications(58), Immunotherapy and Immune Responses(44), RNA Interference and Gene Delivery(43), Ultrasound and Cavitation Phenomena(36), Photoacoustic and Ultrasonic Imaging(27)

Publications139 total

A platform for high-throughput and ultrasensitive immunopeptidomics
2026Open Access
Lipid-stabilized ICG nanoaggregates for the photodisruption of vitreous opacities
Materials Today Bio·2026Open Access
Call for Papers: The Prodigious Diversity of Lipid Nanoparticles for Gene Delivery
ACS Bio & Med Chem Au·2025Open Access
Lipid-stabilized ICG Nanoaggregates for the Photodisruption of Vitreous Opacities
2025Open Access
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways
Cell Reports·2025· 9 citedOpen Access
Challenges and opportunities in mRNA vaccine development against bacteria
Nature Microbiology·2025· 6 citedOpen Access
Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation
Molecular Therapy — Nucleic Acids·2025· 2 citedOpen Access
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs
Molecular Therapy — Methods & Clinical Development·2025Open Access
Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy
Journal of Controlled Release·2025· 10 citedOpen Access
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy
Journal for ImmunoTherapy of Cancer·2025· 2 citedOpen Access
Development of a General Purpose Targeted LC-MS Method for Accurate Quantification of the SARS-CoV-2 Spike Protein Expression
2025Open Access
mRNA Galsomes Vaccine Protects Budgerigars Against Virulent Chlamydia psittaci Challenge
Vaccines·2025· 2 citedOpen Access
Lipid Nanoparticles as a Tool to Dissect Dendritic Cell Maturation Pathways
SSRN Electronic Journal·2025Open Access
Current State of mRNA Vaccine Development Against <i>Mycobacterium tuberculosis</i>
2024Open Access
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways
2024Open Access
The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs
Molecular Therapy — Nucleic Acids·2024· 3 citedOpen Access
Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool
Journal of Controlled Release·2024· 8 citedOpen Access
Immunopeptidomics Mapping of Listeria monocytogenes T Cell Epitopes in Mice
Molecular & Cellular Proteomics·2024· 10 citedOpen Access
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria
Journal of Controlled Release·2024· 31 citedOpen Access
Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy
Trends in cancer·2024· 15 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Stefaan C. De Smedt(40), Heleen Dewitte(18), Rein Verbeke(13), Niek N. Sanders(12), Bart Geers(10), Joseph Demeester(9), Guillaume Lajoinie(8), Michel Versluis(8), Karine Breckpot(8), Ine De Cock(7), Joke Deprez(6), Roosmarijn E. Vandenbroucke(6), Kevin Braeckmans(5), Silke Roovers(4), Jo Demeester(4), Stephen Meairs(4), Eleanor Stride(3), Ying Luan(3), Nico de Jong(3), Liesbeth Peeters(3)